United States · FDA National Drug Code directory
Loratadine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70010-162_346155e4-f155-2f14-e063-6294a90ac61f
- Product NDC
- 70010-162
- Form
- TABLET
- Composition / generic term
- Loratadine
- Labeler
- Granules Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200101
- Source listing expiry
- 20261231
Source-listed ingredients
- LORATADINE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (70010-162-01) · 70010-162-01
- 30 TABLET in 1 BOTTLE (70010-162-03) · 70010-162-03
- 300 TABLET in 1 BOTTLE (70010-162-34) · 70010-162-34
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →